N-[(1R,3R)-3-(2,3-Dihydro-benzofuran-4-yl)-2,2-dimethyl-cyclopropanecarbonyl]-guanidine

ID: ALA51879

Chembl Id: CHEMBL51879

Cas Number: 230640-88-7

PubChem CID: 9925502

Max Phase: Preclinical

Molecular Formula: C15H19N3O2

Molecular Weight: 273.34

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Synonyms: BMS-284640 | BMS-284640|230640-88-7|Cyclopropanecarboxamide, N-(aminoiminomethyl)-3-(2,3-dihydro-4-benzofuranyl)-2,2-dimethyl-, (1R,3R)-|UNII-XP87V064PV|XP87V064PV|(+)-BMS-284640|CHEMBL51879|(1R,3R)-N-(diaminomethylidene)-3-(2,3-dihydro-1-benzofuran-4-yl)-2,2-dimethylcyclopropane-1-carboxamide|SCHEMBL13285838|BDBM50104844|AKOS040750850|Q27293948|N-[(1R,3R)-3-(2,3-Dihydro-benzofuran-4-yl)-2,2-dimethyl-cyclopropanecarbonyl]-guanidine|(1r,3r)-N-(diaminomethylene)-3-(2,3-dihydro-1-benzofuran-4-yl)-2Show More

Canonical SMILES:  CC1(C)[C@H](C(=O)N=C(N)N)[C@H]1c1cccc2c1CCO2

Standard InChI:  InChI=1S/C15H19N3O2/c1-15(2)11(12(15)13(19)18-14(16)17)9-4-3-5-10-8(9)6-7-20-10/h3-5,11-12H,6-7H2,1-2H3,(H4,16,17,18,19)/t11-,12+/m1/s1

Standard InChI Key:  BSKQEHDSFIRYHK-NEPJUHHUSA-N

Associated Targets(Human)

SLC9A1 Tchem Sodium/hydrogen exchanger 1 (412 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC9A2 Tchem Sodium/hydrogen exchanger 2 (37 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC9A3 Tclin Sodium/hydrogen exchanger 3 (483 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC9A5 Tchem Sodium/hydrogen exchanger 5 (22 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 273.34Molecular Weight (Monoisotopic): 273.1477AlogP: 1.16#Rotatable Bonds: 2
Polar Surface Area: 90.70Molecular Species: BASEHBA: 2HBD: 2
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.63CX LogP: 0.97CX LogD: -0.21
Aromatic Rings: 1Heavy Atoms: 20QED Weighted: 0.62Np Likeness Score: 0.23

References

1. Ahmad S, Ngu K, Combs DW, Wu SC, Weinstein DS, Liu W, Chen BC, Chandrasena G, Dorso CR, Kirby M, Atwal KS..  (2004)  Aminoimidazoles as bioisosteres of acylguanidines: novel, potent, selective and orally bioavailable inhibitors of the sodium hydrogen exchanger isoform-1.,  14  (1): [PMID:14684323] [10.1016/j.bmcl.2003.09.066]
2. Ahmad S, Doweyko LM, Dugar S, Grazier N, Ngu K, Wu SC, Yost KJ, Chen BC, Gougoutas JZ, DiMarco JD, Lan SJ, Gavin BJ, Chen AY, Dorso CR, Serafino R, Kirby M, Atwal KS..  (2001)  Arylcyclopropanecarboxyl guanidines as novel, potent, and selective inhibitors of the sodium hydrogen exchanger isoform-1.,  44  (20): [PMID:11563929] [10.1021/jm010100v]
3.  (2014)  NHE3-binding compounds and methods for inhibiting phosphate transport, 
4.  (2013)  Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders, 
5. Talele TT..  (2018)  Natural-Products-Inspired Use of the gem-Dimethyl Group in Medicinal Chemistry.,  61  (6): [PMID:28850227] [10.1021/acs.jmedchem.7b00315]
6.  (2016)  Nhe3-binding compounds and methods for inhibiting phosphate transport,